Zusammenfassung
Verschiedene meist hereditär bedingte Stoffwechselstörungen können zu einer progressiven glomerulären Nierenerkrankung führen, entweder im Rahmen einer generalisierten Kapillarschädigung (Diabetes mellitus), einer glomerulären Hyperfiltration (ebenfalls Diabetes mellitus, Glykogenose Typ 1) oder infolge einer glomerulären Ablagerung abnormer Substanzen (Morbus Fabry, Amyloidose). Zur letzten Gruppe gehören noch weitere Erkrankungen, z.B. Alagille-Syndrom, Lezithin-Cholesterin-Acyltransferasemangel, Lipoprotein-Glomerulopathie); hierfür sei auf die Standardwerke über hereditäre Stoffwechselerkrankungen verwiesen (Desnick et al. 2001).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH (2000) Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 57: 601–606
Caliskan S, Ficicioglu C, Hacibekiroglu M et al. (1997) Tubular markers in children with insulin-dependent diabetes mellitus. Turk J Pediatr 39: 213–218
Cazeneuve C, Sarkisian T, Pecheux C et al. (1999) MEFVgene analysis in armenian patients with familial Mediterranean fever: Diagnostic value and unfavorable renal prognosis of the M694 V homozygous genotype—genetic and therapeutic implications. Am J Hum Genet 65: 88–97
Cooper ME (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352: 213–219
Desnick RJ, Ioannou YA, Eng CM. (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver R, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733–3774
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 Diabetes 4 years after a trial of intensive therapy. N Engl J Med 342: 381–389
Gubler MC, Lenoir G, Grunfeld JP, Ulmann A, Droz D, Habib R (1978) Early renal changes in hemizygous and heterozygous patients with Fabry’s disease. Kidney Int 13: 223–235
Jadoul M, Dode C, Cosyns JP et al. (2001) Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene. Kidney Int 59: 1677–1682
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD for The Collaborative Study Group (1993) The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462
Majeed HA, Rawashdeh M, el-Shanti H, Qubain H, Khuri-Bulos N, Shahin HM (1999) Familial Mediterranean fever in children: The expanded clinical profile. Q J Med 92: 309–318
Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving HH (1999) Randomised controlled trial of long term efficacy of Captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. Br Med J 319: 24–25
Praet M, Quatacker J, Van Loo A, Vanholder R, Lameire N, Ringoir S (1995) Non-invasive diagnosis of Fabry’s disease by electronmicroscopic evaluation of urinary sediment. Nephrol Dial Transplant 10: 902–903
Rawashdeh MO, Majeed HA (1996) Familial Mediterranean fever in Arab children: The high prevalence and gene frequency. Eur J Pediatr 155: 540–544
Reitsma-Bierens WC (1993) Renal complications in glycogen storage disease type I. Europ J Pediatr 152 (Suppl 1): S60–S62
Restaino I, Kaplan BS, Stanley C, Baker L (1993) Nephrolithiasis, hypocitraturia, and a distal renal tubular acidification defect in type 1 glycogen storage disease. J Pediatr 122: 392–396
Saatci U, Ozen S, Özdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: Report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156: 619–623
Said R, Hamzeh Y, Said S, Tarawneh M, al-Khateeb M (1992) Spectrum of renal involvement in familial Mediterranean fever. Kidney Int 41: 414–419
Sarkissian A, Papazian M, Sanamyan A, Leumann E (2000) Colchicine in the treatment of renal amyloidosis secondary to familial Mediterranean fever. Nephrol Dial Transplant 15: 1098
Sheth KJ, Roth DA, Adams MB (1983) Early renal failure in Fabry’s disease. Am J Kidney Dis 2: 651–654
Smit GP (1993) The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr 152(Suppl 1): S52–S55
Veiga-da-Cunha M, Gerin I, Chen YT et al. (1999) The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet 7: 717–723
Walker JD, Close CF, Jones SL, Rafftery M, Keen H, Viberti G, Osterby R (1992) Glomerular structure in type-1 (insulindependent) diabetic patients with normo-and microalbuminuria. Kidney Int 41: 741–748
Wüthrich RP, Weinreich T, Binswanger U, Gloor HJ, Candinas D, Hailemariam S (1998) Should living related kidney transplantation be considered for patients with renal failure due to Fabry’s disease? Nephrol Dial Transplant 13: 2934–2936
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leumann, E.P. (2002). Metabolische Erkrankungen mit glomerulärer Beteiligung. In: Schärer, K., Mehls, O. (eds) Pädiatrische Nephrologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56378-2_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-56378-2_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62621-0
Online ISBN: 978-3-642-56378-2
eBook Packages: Springer Book Archive